Peptides, conjugates and method for increasing immunogenicity of a vaccine
US9522962B2 · kind B2 · utility
2Cited by
2References
16Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 15, 2011 |
| Grant date | Dec 20, 2016 |
| Priority date | — |
| Expiry date | Feb 15, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/627
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to conjugates comprising a peptide of at least 10 amino acid residues comprising the amino acid sequence GITELKKL (residues 383-390 of SEQ ID NO: 3) for induction of potent humoral and cellular immune responses when administered to subjects having antibodies against tetanus toxoid. In one embodiment the invention relates to a prophylactic and therapeutic vaccine and in a further embodiment the invention relates to the treatment or prevention of cancer or an infectious disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.